A development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity its associated co-morbidities and other gastrointestinal disorders.


Updates from The Motley Fool

Latest updates on EnteroMedics from Fool.com.


Stock Performance

ETRM vs. S&P 500 | 2 Year Performance
View Interactive ETRM Charts
Sponsored by

Key Data Points

Primary metrics and data points about EnteroMedics.
Current Price: $0.19
Prev Close: $0.19
Open: $0.20
Bid: $0.19
Ask: $0.19
Day's Range: $0.18 - $0.20
52wk Range: $0.16 - $5.85
Volume: 5,248,647
Avg Vol 5,527,928
Market Cap: $1.31M
P/E (ttm): -0.07
EPS (ttm): -$2.67
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about EnteroMedics.
CAPS Rating 2 out of 5
 
49 Outperform
9 Underperform
CAPS All Stars
 
12 Outperform
3 Underperform

How do you think EnteroMedics will perform against the market?



You pick for EnteroMedics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark B. Knudson, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for EnteroMedics.

A development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity its associated co-morbidities and other gastrointestinal disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT